1. Evaluating the Relationship Between Hypertriglyceridemia and Cardiovascular Risk

2. Case Study: 45-year-old Man

3. Case Study: 45-year-old Man (cont)

4. Medications and Lab Results

5. Primary Causes of Hypertriglyceridemia

6. Secondary Causes of Hypertriglyceridemia

7. Triglyceride Level Is a Significant CVD Risk Factor: Recent Meta-Analysis of 29 Studies

8. ATP III Treatment Recommendations for Elevated TGs

9. The Chemical Differences Between EPA and DHA

10. Select Omega-3 Outcomes Studies

11. Icosapent Ethyl (Pure EPA): Median Placebo-Adjusted Change From Baseline for Efficacy End Points

15. ANCHOR: Icosapent Ethyl Change in Lipid End Points

16. Reduction of Cardiovascular Events With EPA – Intervention Trial

17. Primum Non Nocere

18. Abbreviations

19. Abbreviations (cont)

20. Abbreviations (cont)

21. References

22. References (cont)

23. References (cont)

24. References (cont)